Insight Molecular Diagnostics (IMDX) Net Margin (2020 - 2026)
Insight Molecular Diagnostics (IMDX) posted Net Margin of 13790.62% for Q1 2026, down 584.27% sequentially from 2015.36% in Q4 2025, and down 1347860.0% YoY from N/an in Q1 2025.
Insight Molecular Diagnostics (IMDX) Net Margin (2020 - 2026) Analysis & Trends
Insight Molecular Diagnostics (IMDX) has 7 years of Net Margin data on file, last reported at 13790.62% in Q1 2026.
- Quarterly Net Margin fell 1347860.0% year-over-year to 13790.62% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2460.95% (down 94490.0% YoY) and the FY2025 annual result came in at 1238.52%, up 200050.0% from the prior year.
- Net Margin eased to 13790.62% in Q1 2026 per IMDX's latest filing, from 2015.36% in the prior quarter.
- The five-year high for Net Margin was 3316.06% in Q4 2022, with the low at 14368.66% in Q3 2022.
- Average Net Margin over 5 years is 4165.88%, with a median of 2708.16% recorded in 2022.
- Year-over-year, Net Margin soared 1280992 bps in 2023 and slumped 1347860 bps in 2026.
- Insight Molecular Diagnostics' Net Margin stood at 3316.06% in 2022, then sank by 227 bps to 4225.8% in 2023, then jumped by 47 bps to 2255.11% in 2024, then increased by 11 bps to 2015.36% in 2025, then tumbled by 584 bps to 13790.62% in 2026.
- Business Quant data shows IMDX's Net Margin at 13790.62% in Q1 2026, 2015.36% in Q4 2025, and 4174.62% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -5.68% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 15.06% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 17.29% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 24.41% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -12.22% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 18.47% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 3.40% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 12.28% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 17.89% |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 | -13,790.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,790.63% |
| Dec 31, 2025 | -2,015.36% |
| Sep 30, 2025 | -4,174.62% |
| Jun 30, 2025 | -1,880.69% |
| Mar 31, 2025 | -312.02% |
| Dec 31, 2024 | -2,255.11% |
| Sep 30, 2024 | -11,733.04% |
| Jun 30, 2024 | -4,410.58% |
| Mar 31, 2024 | -5,303.98% |
| Dec 31, 2023 | -4,225.80% |
| Sep 30, 2023 | -1,558.74% |
| Jun 30, 2023 | -1,866.95% |
| Mar 31, 2023 | 0.81% |
| Dec 31, 2022 | 3,316.06% |
| Sep 30, 2022 | -14,368.66% |
| Jun 30, 2022 | -3,532.49% |
| Mar 31, 2022 | -2,708.16% |
| Dec 31, 2021 | -999.86% |
| Sep 30, 2021 | -1,402.44% |
| Jun 30, 2021 | -516.90% |